Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Mar 19;14(6):458.
doi: 10.3390/cells14060458.

A Comprehensive Exploration of the Biological Effects of Adipose-Derived Stem Cells in the Treatment of Systemic Sclerosis

Affiliations
Review

A Comprehensive Exploration of the Biological Effects of Adipose-Derived Stem Cells in the Treatment of Systemic Sclerosis

Gabriele Storti et al. Cells. .

Abstract

Systemic sclerosis (SSc) is a complex autoimmune disease characterized by vasculopathy and tissue fibrosis affecting the skin and internal organs. Genetic and environmental factors influence susceptibility, severity, and onset. Current treatments are limited and not always effective, leading researchers to investigate new approaches, such as the use of adipose-derived mesenchymal stem cells (ADSCs) through fat grafting. This review seeks to understand how ADSCs may impact the development and progression of SSc, with a particular focus on how these cells could alter immune responses and reduce fibrosis. ADSCs have been found to affect various immune cells, including T cells, B cells, macrophages, and dendritic cells, by releasing cytokines, chemokines, and growth factors. These interactions generally suppress inflammation and promote a regulatory immune environment. Additionally, ADSCs can influence the extracellular matrix, helping to prevent fibrosis through signaling molecules like exosomes. ADSCs show promise as a treatment for SSc due to their ability to modulate the immune system and reduce fibrosis. Early clinical studies are encouraging, but more research is needed to fully understand how they work and to develop effective treatment protocols.

Keywords: ADSC; lipofilling; systemic sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The Coleman technique involves the harvesting of adipose tissue, centrifugation, and the removal of the oily portion, as well as the part containing blood and local anesthetic. The fat graft is then injected into the recipient areas.
Figure 2
Figure 2
The injection of the adipose-derived stem cells (ADSCs) in the skin areas affected by systemic sclerosis (SSc) acts through different biological pathways, which ultimately determine multiple clinical effects. Abbreviation: SVF (stromal vascular fraction).
Figure 3
Figure 3
ADSCs exert their pro-angiogenic role by releasing VEGF, HGF, and bFGF, which stimulate angiogenesis.

Similar articles

References

    1. Bergamasco A., Hartmann N., Wallace L., Verpillat P. Epidemiology of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease. Clin. Epidemiol. 2019;11:257–273. doi: 10.2147/CLEP.S191418. - DOI - PMC - PubMed
    1. Maria A.T.J., Maumus M., Le Quellec A., Jorgensen C., Noël D., Guilpain P. Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis. Clin. Rev. Allergy Immunol. 2017;52:234–259. doi: 10.1007/s12016-016-8552-9. - DOI - PubMed
    1. Foti R., Storti G., Palmesano M., Scioli M.G., Fiorelli E., Terriaca S., Cervelli G., Kim B.S., Orlandi A., Cervelli V. Senescence in Adipose-Derived Stem Cells: Biological Mechanisms and Therapeutic Challenges. Int. J. Mol. Sci. 2024;25:8390. doi: 10.3390/ijms25158390. - DOI - PMC - PubMed
    1. Ruhl T., Storti G., Pallua N. Proliferation, Metabolic Activity, and Adipogenic Differentiation of Human Preadipocytes Exposed to 2 Surfactants In Vitro. J. Pharm. Sci. 2018;107:1408–1415. doi: 10.1016/j.xphs.2017.12.017. - DOI - PubMed
    1. Storti G., Scioli M.G., Kim B.-S., Terriaca S., Fiorelli E., Orlandi A., Cervelli V. Mesenchymal Stem Cells in Adipose Tissue and Extracellular Vesicles in Ovarian Cancer Patients: A Bridge toward Metastatic Diffusion or a New Therapeutic Opportunity? Cells. 2021;10:2117. doi: 10.3390/cells10082117. - DOI - PMC - PubMed

Publication types

LinkOut - more resources